ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Immunologists Boycott USSR Trip; Centers Program Staff Reorganized, Trimmed Down

June 2, 1978

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

August 30, 2013

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

National Academy Of Sciences To form Cancer Policy Board At NCI’s Request

August 16, 1996

In Brief: Byrd Heads ACS, Lee Clark President-Elect; NCI Needs Community Medical Oncologist

November 7, 1975

Prostate Cancer: NIH Pans To Ramp Up Prostate Cancer Research Funding

June 25, 1999